普伦巴丁向GLUT1/MMP-2轴以抑制口腔状细胞癌的进展
Fei He1,2, Weiqi Wang3, Sadam Ahmed Elayah4
1Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, 98 West 5th Road, Xi'an, Shaanxi, 710004, China.
Cancer cell international
|July 29, 2025
概括
巴丁 (PLB) 通过降低葡萄糖载体1 (GLUT1) 和矩阵金属蛋白酶2 (MMP2) 的下调来抑制口腔平细胞癌 (OSCC) 侵袭和转移. 这为PLB提供了基础.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 口腔状细胞癌 (OSCC) 是一种流行癌症,患病率很高.
- 葡萄糖载体1 (GLUT1) 和矩阵金属蛋白酶2 (MMP2) 都与癌症进展有关.
- 素 (PLB) 是一种具有潜在抗癌性能的天然化合物.
研究的目的:
- 研究GLUT1在OSCC中的临床病理特征和预后价值.
- 通过GLUT1/MMP2通路探索PLB对OSCC入侵和转移的抑制作用.
主要方法:
- 分析了120个OSCC标本,使用免疫组织化学检测GLUT1表达.
- 使用OSCC细胞系 (Cal27,SCC9) 的体外和体内研究来评估PLB的影响.
- 使用GLUT1抑制剂 (WZB117) 来验证发现.
主要成果:
- 在OSCC中,GLUT1表达与MMP2,瘤复发,淋巴转移和TNM阶段相关.
- 通过降低GLUT1和MMP2的调节,PLB显著抑制OSCC细胞的增殖,迁移和入侵.
- 此外,WZB117还减少了OSCC细胞殖民地形成,迁移和入侵.
- GLUT1表达不是OSCC生存的独立预后标志物.
结论:
- 普伦巴通过抑制OSCC中的GLUT1/MMP2轴,表现出一种新的抗癌机制.
- PLB有效地抑制了OSCC的入侵和迁移.
- 这些发现支持plumbagin在OSCC治疗中的潜在临床应用.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Gene Regulation in Microbial Communities: Quorum Sensing
93
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
93
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
263
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
263
Glucagon-like Receptor Agonists
420
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
420
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K


